ADIAL PHARMACEUTICALS, INC. (ADIL) › Shareholders' EquityADIAL PHARMACEUTICALS, INC. (ADIL) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2016: -$103.5K2017: -$997.6K2018: $4.44M2019: $7.14M2020: $3.99M2021: $3.51M2022: $3.28M2023: $4.08M2024: $4.07M2025: $5.28M$5.28M2016Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$5.28M+29.7%2024$4.07M-0.4%2023$4.08M+24.6%2022$3.28M-6.6%2021$3.51M-12.0%2020$3.99M-44.2%2019$7.14M+60.8%2018$4.44M+545.2%2017-$997.6K-863.9%2016-$103.5K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share